AEON Biopharma (AEON) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Lake Street | Maintained | Buy | $2.00 from $1.00 | Oct 1, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $1.20 from $5.00 | Aug 14, 2026 |
| Aegis Capital | Maintained | Buy | $7.20 | Oct 8, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Oct 1, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $6.00 | Aug 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Jul 10, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | May 30, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 from $18.00 | May 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | May 6, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $18.00 | Apr 17, 2024 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $18.00 | Aug 18, 2023 |
Frequently asked questions
Is AEON a buy, sell, or hold?
Analysts covering AEON Biopharma currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on AEON?
On Oct 1, 2026, Lake Street maintained AEON Biopharma at Buy with a price target of $2.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.